Skip to main content
. Author manuscript; available in PMC: 2017 Oct 15.
Published in final edited form as: Cancer Res. 2016 Aug 15;76(20):5933–5944. doi: 10.1158/0008-5472.CAN-16-0346

Figure 5.

Figure 5

ROC curves for pathologic complete response using percent change from baseline to mid-therapy in TOITN (%TOITN) A) in the overall evaluable dataset, B) in the subset of evaluable cases with baseline tumor saturation lower than the median value, C) in the subset of evaluable cases with baseline tumor saturation greater than the median value. The reference standard is coded as follows: 0=pCR and 1=Non-pCR.